![Hamilton-Halton Investment announced for six innovators by the federal government.](https://synapseconsortium.com/wp-content/uploads/2024/07/Hamilton-Halton-Investment-320x184.jpg)
Jul-2024
Discover how the Government of Canada is boosting innovation with over $8.5 million in federal support for sectors in Halton and Hamilton.
![Image of a lab researcher in the background.](https://synapseconsortium.com/wp-content/uploads/2024/06/Mohawk-Medbuy-PR-320x184.jpg)
Learn about the new consortium partnership with Mohawk Medbuy to help life sciences innovators within the Hamilton-Halton region.
![Two researchers from McMaster in a lab as a backdrop to the Title McMaster and Kapoose Creek Bio set sights on new fungi-derived medicines in new $2.2M drug discovery partnership](https://synapseconsortium.com/wp-content/uploads/2024/06/iF-Website-News-Posts-Featured-Images-320x184.jpg)
Researchers at Kapoose Creek Bio partner with McMaster University to develop a new synthetic biology platform for fungi-derived medicines.
![Image of the doctor who created the medtech device](https://synapseconsortium.com/wp-content/uploads/2024/06/HHS-News-post-320x184.jpg)
The Ontario Centre of Innovation recently announced $500,000 in provincial funding to expand a made-in-Hamilton smartphone app into the Ottawa region.
![How femtech companies are tackling gender health gaps while empowering women. From left to right: Rachel Bartholomew, CEO and Founder of Hyivy Health, Nadia Ladak, CEO and Co-founder of Marlow, Dallas Barnes, CEO and founder of Reya Health](https://synapseconsortium.com/wp-content/uploads/2024/05/How-femtech-companies-are-tackling-gender-health-gaps-while-empowering-women-320x184.jpg)
Growing a femtech company brings more challenges than successes, but these founders are focused on closing the women’s healthcare gap.
![](https://synapseconsortium.com/wp-content/uploads/2024/05/Synapse-Consortium-McMaster-and-UofO-Funding-PR-320x184.jpg)
May-2024
McMaster and University of Ottawa recieved funding from CBRF to expand Canada’s biomanufacturing industry for development of technology and theraputics.
![Success stories inspire the next generation of unicorn founders. Background image shows a diverse group of entrepreneurs celebrating business success in a bright office environment.](https://synapseconsortium.com/wp-content/uploads/2024/04/iF_Synapse_Fusion_FluidAI_story-320x184.jpg)
Blockbuster AstraZeneca-Fusion Pharmaceuticals announcement shows Hamilton’s life science innovation ecosystem is thriving.
![In the news: Fusion Pharmaceuticals. The background image is a woman researcher working in a lab while wearing personal protective equipment (PPE).](https://synapseconsortium.com/wp-content/uploads/2024/03/Fusion-Pharmaceuticals-1-320x184.png)
Hamilton-based Fusion Pharmaceuticals Inc. has entered into a definitive agreement to be acquired by AstraZeneca.
![WiHI](https://synapseconsortium.com/wp-content/uploads/2024/01/OBIO-WiHI-award-320x184.jpg)
Jan-2024
11 women-led companies have been selected for the OBIO® WiHI Seed Program.
![PreOperative Performance is a SOPHIE company partnering with The Research Institute of St. Joes Hamilton to to help neuroradiologists to assess the quality and consistency of MRI diffusion imaging protocols.](https://synapseconsortium.com/wp-content/uploads/2023/06/PreOperative-Performance-SOPHIE-320x184.jpg)
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton (RSJH) to evaluate technology that aims to help radiology groups make better quality measurements of MRI machines. This press release was originally shared by PreOperative Performance through Newswire on June 14, 2023. Read the original […]